Hayashi C, Takada S, Kasuga A, Shinya K, Watanabe M, Kano H, Takayama T.
Sigmoid-vaginal fistula during bevacizumab treatment diagnosed by fistulography.
J Clin Pharm Ther 2016;
41:725-726. [PMID:
27624676 DOI:
10.1111/jcpt.12454]
[Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2016] [Accepted: 08/23/2016] [Indexed: 11/26/2022]
Abstract
WHAT IS KNOWN AND OBJECTIVE
There have been several reports describing rectovaginal fistula development after bevacizumab treatment, and these fistulas were diagnosed by CT scan or colonoscopy. We report a case of sigmoid-vaginal fistula diagnosed by fistulography.
CASE DESCRIPTION
The case is a 53-year-old woman who was treated for chronic myelogenous leukaemia and gynaecological cancers 8 years previously. At 52 years of age, she was diagnosed with colon cancer and had a partial colectomy performed. One year after surgery, colon cancer recurred, and she was treated with anticancer agents, including bevacizumab. During chemotherapy, she complained of a foul smelling discharge from the vagina. Fistulography revealed a sigmoid-vaginal fistula.
WHAT IS NEW AND CONCLUSION
This is the first report of vaginal fistulography performed on a patient who was treated with bevacizumab. Fistulography may be useful for detecting sigmoid-vaginal fistula.
Collapse